topotecan has been researched along with Carcinoma, Adenosquamous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brewster, WR; Burger, RA; Gatcliffe, TA; Kuo, JV; Monk, BJ; Shah, A; Tewari, KS | 1 |
Babilonti, L; Cormio, G; Ditto, A; Franchi, M; Ghezzi, F; Giorda, G; Giudici, S; Grijuela, B; Lorusso, D; Lorusso, M; Raspagliesi, F; Scambia, G; Zanaboni, F | 1 |
2 trial(s) available for topotecan and Carcinoma, Adenosquamous
Article | Year |
---|---|
A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Feasibility Studies; Female; Humans; Middle Aged; Neoplasm Staging; Survival Rate; Topotecan; Uterine Cervical Neoplasms | 2009 |
Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Drug Administration Schedule; Female; Humans; Middle Aged; Neoadjuvant Therapy; Topotecan; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2013 |